ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1033–1044 of 2020 project topics
Promoter and Enhancer Variant Effect Prediction
Developing machine learning models trained on regulatory element data for predicting transcriptional effects of non-coding variants.
Functional Annotation of Non-Coding Genome Click to view more details →
CRISPRi Screen of Non-Coding GWAS Loci
Performing tiling CRISPRi screens across GWAS signal regions for identifying functional regulatory elements controlling disease-relevant gene expression.
Functional Annotation of Non-Coding Genome Click to view more details →
3D Chromatin Architecture Mapping for Drug Target Discovery
SaaS platforms integrate Hi-C, Micro-C, and live-cell imaging data to map 3D genome structure and identify long-range regulatory interactions affecting gene expression. Pharmaceutical companies accelerate target validation and reduce failed drug development cycles by predicting regulatory landscapes for precision medicine applications.
Functional Annotation of Non-Coding Genome Click to view more details →
Non-Coding Variant Interpretation Pipeline for Clinical Diagnostics
Cloud-based diagnostic tools combine multi-omics data, conservation scores, and machine learning models to classify disease-causing non-coding variants with clinical actionability. Diagnostic labs and hospitals generate recurring SaaS revenue while improving diagnostic yield for patients with suspected genetic disorders.
Functional Annotation of Non-Coding Genome Click to view more details →
Machine Learning Models for Splice Site and UTR Variant Effects
Commercial deep learning platforms predict functional consequences of splice-altering and UTR variants across diverse genetic backgrounds and tissue contexts. Rare disease companies and research labs license these models to discover novel therapeutic targets and patient stratification biomarkers.
Functional Annotation of Non-Coding Genome Click to view more details →
Tissue-Specific Enhancer Activity Prediction for Therapeutics Development
Enterprise software uses cell type-specific epigenomic data and machine learning to predict tissue-restricted enhancer function and off-target regulatory effects. Biotech companies reduce safety liabilities and accelerate lead optimization by validating enhancer-based therapeutic targets before clinical development.
Functional Annotation of Non-Coding Genome Click to view more details →
LncRNA and Circular RNA Functional Annotation Platform
Integrated bioinformatics platforms combine sequence conservation, secondary structure prediction, and experimental datasets to assign functional roles to long non-coding and circular RNAs. Genomics companies monetize through subscription licenses to pharmaceutical R&D teams developing RNA-targeted therapeutics.
Functional Annotation of Non-Coding Genome Click to view more details →
Variant Effect Database and Scoring Infrastructure for Rare Diseases
Commercial curated databases and APIs aggregate experimental evidence, population data, and computational predictions to score non-coding variant pathogenicity for clinical interpretation. Diagnostic providers and research consortia pay for managed data infrastructure and real-time variant scoring services supporting precision medicine workflows.
Functional Annotation of Non-Coding Genome Click to view more details →
Short Stature Gene Panel Testing
Developing comprehensive short stature gene panels covering GH1, GHR, IGF1, SHOX, and other growth axis genes for molecular diagnosis.
Genetic Basis of Growth Disorders Click to view more details →
Silver-Russell Syndrome Molecular Diagnosis
Testing H19/IGF2 methylation, upd(7)mat, and 11p15 duplications causing Silver-Russell syndrome for molecular classification and growth hormone therapy decisions.
Genetic Basis of Growth Disorders Click to view more details →
Beckwith-Wiedemann Syndrome Genetics
Characterizing 11p15 imprinting defects including methylation changes and UPD causing BWS for Wilms tumor surveillance and management.
Genetic Basis of Growth Disorders Click to view more details →
Tall Stature and Overgrowth Syndrome Genetics
Investigating PTEN, NSD1, and other genes causing overgrowth syndromes for molecular diagnosis and cancer surveillance recommendations.
Genetic Basis of Growth Disorders Click to view more details →